<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02264834</url>
  </required_header>
  <id_info>
    <org_study_id>PDB001</org_study_id>
    <nct_id>NCT02264834</nct_id>
  </id_info>
  <brief_title>Deambulatory Epidural During the Labour</brief_title>
  <official_title>Comparison of Two Different Peridural During the Labor and Effect of Deambulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr Madeleine Wilwerth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the impact of instrumentation and caesarean related to dyskinesia by reducing the
      concentration of local anesthetic and therefore the motor block.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, randomized and double-blind study performed on primiparous parturient divided
      into two distinct groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time between peridural application and childbirth</measure>
    <time_frame>at delivery</time_frame>
    <description>This will be used to assess labor.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Caesarian</measure>
    <time_frame>at delivery</time_frame>
    <description>This will be used to assess labor. Was a caesarian necessary (yes-no) ?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Instrumentalisation</measure>
    <time_frame>at delivery</time_frame>
    <description>This will be used to assess labor. Was an instrumentalisation (defined as the use of forceps or suction cups) necessary at delivery (yes-no) ?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Apgar score of the baby</measure>
    <time_frame>at delivery</time_frame>
    <description>Evaluation of the baby, using the Apgar score. This will be used to assess labor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bromage score</measure>
    <time_frame>1h after the start of the peridural</time_frame>
    <description>Modified Bromage score (Breen et al) &gt;5 and ability to stand on one leg alternatively. This will be used to assess perambulation (motricity).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Romberg test</measure>
    <time_frame>1h after the start of the peridural</time_frame>
    <description>Romberg test during 20-30 seconds. This will be used to assess perambulation (proprioception).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial tension</measure>
    <time_frame>1h after the start of the peridural</time_frame>
    <description>Absence of orthostatic hypotension (i-e less than 20% of the usual arterial tension of the patient).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">340</enrollment>
  <condition>First Pregnancy</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lumbar epidural analgesia during the labour and end up after delivery Levobupivacaine 0.1% + Sufentanil 0.2 µg/mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ambulatory group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lumbar epidural analgesia during the labour and end up after delivery Levobupivacaine 0.07% + Sufentanil 0.3 µg/mL</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0.1% + Sufentanil 0.2µg/ml</intervention_name>
    <description>Levobupivacaine 0.1% + Sufentanil 0.2µg/ml</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>control group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0.07% + Sufentanil 0.3µg/ml</intervention_name>
    <description>Levobupivacaine 0.07% + Sufentanil 0.3µg/ml</description>
    <arm_group_label>Ambulatory group</arm_group_label>
    <other_name>ambulatory group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lumbar epidural analgesia</intervention_name>
    <description>Introduction of a catheter in lumbar epidural space</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Ambulatory group</arm_group_label>
    <other_name>labor analgesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Free written consent.

          -  ASA I or II,

          -  Primipara, unique and pregnancy over 36 weeks fetus in cephalic, cervical dilation
             between 3-6 cm

          -  VAS&gt; 30 mm

          -  No contraindications to peridural

        Exclusion Criteria:

          -  Twin pregnancy, less than 36 weeks and 42 weeks

          -  Fetus in breech position

          -  Analgesia and sedation within 6h

          -  Contraindications to peridural
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Vanderlinden</last_name>
    <role>Study Director</role>
    <affiliation>CHUB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manon Lalmand, MD</last_name>
    <phone>+3224753090</phone>
    <email>Manon.LALMAND@chu-brugmann.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gauthier Gamela, MD</last_name>
    <phone>+3224772111</phone>
    <email>gauthier.gamela@chu-brugmann.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHUB</name>
      <address>
        <city>Bruxelles</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manon Lalmand, MD</last_name>
      <phone>+3224753090</phone>
      <email>Manon.LALMAND@chu-brugmann.be</email>
    </contact>
    <contact_backup>
      <last_name>Gautier Gamela, MD</last_name>
      <phone>+3224772111</phone>
      <email>gauthier.gamela@chu-brugmann.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2014</study_first_submitted>
  <study_first_submitted_qc>October 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2014</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Dr Madeleine Wilwerth</investigator_full_name>
    <investigator_title>primary investigator</investigator_title>
  </responsible_party>
  <keyword>epidural</keyword>
  <keyword>primiparous patient</keyword>
  <keyword>deambulation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

